Reduced anti-platelet therapy with pimecrolimus drug eluting stent (RAPID) A multi-center study of the pimecrolimus-eluting cobalt chromium coronary stent system (Corio) in patients with de novo lesions of the native coronary arteries
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2008
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RAPID
- 16 Oct 2008 Status changed from not yet recruiting to discontinued, as reported by ClinicalTrials.gov.
- 08 Nov 2006 New trial record.